Unibest

Pharmaceutical intermediates

Gepotidacin Intermediates

2 pharmaceutical intermediates for Gepotidacin. Indication: Urinary Tract Infection (UTI).

Submit a ProjectAll intermediates

About Gepotidacin

Originator
Glaxosmithkline (Gsk)
Indication
Urinary Tract Infection (UTI)
Approved Date
03/25/2025
NCE Patent
03/25/2035
DS/DP
02/12/2029

Available intermediates

2 intermediates currently listed for Gepotidacin. Request specifications, documentation or a quotation for any item below.

Gepotidacin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethanol527681-60-3//
3,4-dihydro-2H-pyrano[2,3-c]pyridine-6-carbaldehyde527681-61-4//

Other programs under G

GadobutrolGilteritinib

Building toward Gepotidacin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →